HuGE Literature Finder
Records
1
-
7
Effects of Trough Concentration and Solute Carrier Polymorphisms on Imatinib Efficacy in Chinese Patients with Chronic Myeloid Leukemia. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 2020 23 (1): 1-9. Wang Qing, Jiang Zhi-Ping, Zeng Jing, Zhu Yan, Cai Hua-Lin, Xiang Da-Xiong, He Qun, Shi Xiao-Liu, Zhong An-Ni, Zhao Xie-Lan, Xu Pi |
Association between a microRNA binding site polymorphism in SLCO1A2 and the risk of delayed methotrexate elimination in Chinese children with acute lymphoblastic leukemia. Leukemia research 2018 02 65 61-66. Wang Shu-Mei, Zeng Wei-Xin, Wu Wan-Shui, Sun Lu-Lu, Yan D |
MiR-pharmacogenetics of methotrexate in childhood B-cell acute lymphoblastic leukemia. Pharmacogenetics and genomics 2016 Sep . Iparraguirre Leire, Gutierrez-Camino Angela, Umerez Maitane, Martin-Guerrero Idoia, Astigarraga Itziar, Navajas Aurora, Sastre Ana, Garcia de Andoin Nagore, Garcia-Orad Afri |
Relationship between SLCO1B3 and ABCA3 polymorphisms and imatinib response in chronic myeloid leukemia patients. Hematology (Amsterdam, Netherlands) 2015 Apr 20 (3): 137-42. de Lima Luciene Terezina, Bueno Carolina Tosin, Vivona Douglas, Hirata Rosario Domiguez Crespo, Hirata Mario Hiroyuki, Hungria Vania Tiestsche de Moraes, Chiattone Carlos Sérgio, Zanichelli Maria Aparecida, Chauffaille Maria de Lourdes Lopes Ferrari, Guerra-Shinohara Elvira Mar |
Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia. Medical oncology (Northwood, London, England) 2014 Mar 31 (3): 851. de Lima Luciene Terezina, Vivona Douglas, Bueno Carolina Tosin, Hirata Rosario D C, Hirata Mario H, Luchessi André D, de Castro Fabíola Attié, de Lourdes F Chauffaille Maria, Zanichelli Maria A, Chiattone Carlos S, Hungria Vania T M, Guerra-Shinohara Elvira |
Polymorphisms in the methotrexate transport pathway: a new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia. Pharmacogenetics and genomics 2013 Feb 23 (2): 53-61. Lopez-Lopez Elixabet, Ballesteros Javier, Piñan Maria A, Sanchez de Toledo José, Garcia de Andoin Nagore, Garcia-Miguel Purificacion, Navajas Aurora, Garcia-Orad Afri |
Pharmacokinetic impact of SLCO1A2 polymorphisms on imatinib disposition in patients with chronic myeloid leukemia. Clinical pharmacology and therapeutics 2011 Jul 90 (1): 157-63. Yamakawa Y, Hamada A, Shuto T, Yuki M, Uchida T, Kai H, Kawaguchi T, Saito |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 30, 2023
- Content source: